IKT R&D to Revenue
Inhibikase Therapeutics Inc · R&D to Revenue
IKT R&D to Revenue
Latest reported0.00%period ending
IKT FY R&D/Revenue (87.49% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
IKT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 5,227.7727% | |
| 9,749.6638% | |
| 366.3512% | |
| 127.9661% | |
| 227.3644% | |
| 90.2536% | |
| 85.189% | |
| 87.4921% |